Rutherford-based Cancer Genetics Inc., a diagnostics company focused on developing genomic-based oncology tests and services, today announced it has closed its initial public offering of 690,000 shares of common stock at a price to the public of $10 per share.
Read More »
Health Care
Catalent acquires marketing license for Redwood technology
Catalent Pharma Solutions, in the Somerset section of Franklin, on Wednesday announced it has acquired an exclusive license to market Redwood Bioscience’s proprietary SmarTag technology for the development of advanced antibody-drug conjugates.
Read More »Cranbury biotech gets 2.2M to develop dengue vaccine
Cranbury-based biotechnology company VaxInnate Corp. has received a $2.2 million grant from the federal government to develop a vaccine to prevent dengue, a mosquito-borne viral disease that kills about 25,000 people annually worldwide.
Read More »Cooper to acquire stake in AmeriHealth NJ
Cooper University Health Care is acquiring a 20 percent interest in AmeriHealth New Jersey, with the option to purchase additional equity at a later time, in a bid to offer new health plan options for employers and consumers, the companies announced today.
Read More »Quest completes 300M sale of business unit
Madison-based Quest Diagnostics announced Tuesday it has completed the sale of its HemoCue diagnostic products business to Radiometer Medical ApS for approximately $300 million, plus adjustments for cash balances.
Read More »Bristol-Myers Squibb taps new chief scientific officer
Bristol-Myers Squibb Co. on Tuesday announced the appointment of Francis Cuss as executive vice president and chief scientific officer, effective July 1.
Read More »JLL represents Dr. Reddy’s for headquarters lease in Princeton
Jones Lang LaSalle, in Parsippany, announced Tuesday it completed a new, direct lease for 106,500 square feet of office and lab space for Dr. Reddy's Laboratories Inc. with National Business Parks Inc., in Princeton.
Read More »
For hospital systems, careful bets on patient population help chart course for future
The state's hospital systems are moving in opposite directions as they strategize how to deal with the final push of Affordable Care Act implementation. And neither strategy is without risk: While some systems could fall behind the reform movement as they wait to see what happens, others may get too far ahead as new models undergo real-world...
Read More »FDA approves Bausch Lomb drug
Bausch & Lomb, the Madison-based eye health company, today announced the U.S. Food and Drug Administration has approved the company's new drug application for its Prolensa therapy.
Read More »Pay to delay puts Big Pharma, generics in same corner
Pharmaceutical companies and their generic competitors, often courtroom adversaries, are fighting on the same side to protect their right to settle patent disputes out of court through cash payments.
Read More »
Executives racing to assess how insurance reform will change benefits plans, costs
With time ticking, employers are now grappling with complex — and potentially punitive — rules under the Affordable Care Act, which in 2014 levies fines on employers with 50 or more workers who either don't provide health insurance, or whose employees receive federal subsidies to buy coverage because their employer's plan isn't...
Read More »Study reveals populations most in need of health insurance assistance
The expansion of the state's Medicaid program and other Affordable Care Act initiatives will open up health care access to many people, but the state must understand which sociodemographics are most likely to need coverage in order to have a significant impact.
Read More »